Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 201

Moloco hauls in $150m series C round

Already backed by Samsung Ventures and LG Technology Ventures, machine learning adtech company Moloco raised another $150m.

Aug 18, 2021

HiberCell hauls in Genuity Science in acquisition

HiberCell has acquired genomics analytic services provider Genuity Science, which had previously been bought by WuXi AppTec before being spun off last year.

Aug 18, 2021

Sightline snatches $270m at $1bn valuation

Genting Group backed the digital betting payments platform in a funding round led by Cannae Holdings, taking its valuation to over $1bn.

Aug 18, 2021

Spotify-backed DistroKid lists valuation at $1.3bn

Insight Partners has supplied an undisclosed amount for the Spotify-backed independent music distributor at a $1.3bn valuation.

Aug 18, 2021

Daily Deal Round Up: August 17, 2021

National Grid Partners contributed to data protection software provider Baffle's series B round while Axa and Zendesk exited sales enablement platform developer Seismic.

Aug 17, 2021

Chime hits $25bn valuation in $750m round

SoftBank helped the digital financial services provider raise a series G round led by Sequoia Capital, reaching a post-money valuation of $25bn.

Aug 17, 2021

Stewart marches on to M12

GCV Emerging Leader Michael Stewart has taken up a partner role at Microsoft’s M12 subsidiary after a six-year stint at another corporate venture capital unit, Applied Ventures.

Aug 17, 2021

Daily deal net: August 17, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 17, 2021

GentiBio jumps to $157m series A

Matrix Capital Management led the immunology drug developer's series A round, which will support the journey of a type 1 diabetes drug candidate towards the clinic.

Aug 17, 2021

GentiBio jumps to $157m series A

Novartis Venture Fund returned as GentiBio raised money that will support the progress of its type 1 diabetes drug candidate toward clinical trials.

Aug 17, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here